These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18059018)

  • 1. A case report: bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis.
    Squillaro T; Hayek G; Farina E; Cipollaro M; Renieri A; Galderisi U
    J Cell Biochem; 2008 Apr; 103(6):1877-85. PubMed ID: 18059018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rett syndrome: from the gene to the disease.
    Matijevic T; Knezevic J; Slavica M; Pavelic J
    Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
    Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
    Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
    Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
    Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered methylation pattern of the G6 PD promoter in Rett syndrome.
    Huppke P; Bohlander S; Krämer N; Laccone F; Hanefeld F
    Neuropediatrics; 2002 Apr; 33(2):105-8. PubMed ID: 12075494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation.
    Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S
    Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J; Wu H; Sun YE
    Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
    Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
    Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence Phenomena and Metabolic Alteration in Mesenchymal Stromal Cells from a Mouse Model of Rett Syndrome.
    Squillaro T; Alessio N; Capasso S; Di Bernardo G; Melone MAB; Peluso G; Galderisi U
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.
    Philippe C; Villard L; De Roux N; Raynaud M; Bonnefond JP; Pasquier L; Lesca G; Mancini J; Jonveaux P; Moncla A; Chelly J; Bienvenu T
    Eur J Med Genet; 2006; 49(1):9-18. PubMed ID: 16473305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations.
    Temudo T; Oliveira P; Santos M; Dias K; Vieira J; Moreira A; Calado E; Carrilho I; Oliveira G; Levy A; Barbot C; Fonseca M; Cabral A; Dias A; Cabral P; Monteiro J; Borges L; Gomes R; Barbosa C; Mira G; Eusébio F; Santos M; Sequeiros J; Maciel P
    Neurology; 2007 Apr; 68(15):1183-7. PubMed ID: 17420401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome.
    Buoni S; Zannolli R; Felice CD; Saponari S; Strambi M; Dotti MT; Castrucci E; Corbini L; Orsi A; Hayek J
    Clin Neurophysiol; 2008 Nov; 119(11):2455-8. PubMed ID: 18842453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation.
    Tejada MI; Peñagarikano O; Rodriguez-Revenga L; Martinez-Bouzas C; García B; Bádenas C; Guitart M; Minguez M; García-Alegría E; Sanz-Parra A; Beristain E; Milá M
    Clin Genet; 2006 Aug; 70(2):140-4. PubMed ID: 16879196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2.
    Tsujimura K; Abematsu M; Kohyama J; Namihira M; Nakashima K
    Exp Neurol; 2009 Sep; 219(1):104-11. PubMed ID: 19427855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MECP2 gene mutation screening in Rett syndrome patients from Croatia.
    Matijević T; Knezević J; Barisić I; Resić B; Culić V; Pavelić J
    Ann N Y Acad Sci; 2006 Dec; 1091():225-32. PubMed ID: 17341617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 involvement in the regulation of neuronal alpha-tubulin production.
    Abuhatzira L; Shemer R; Razin A
    Hum Mol Genet; 2009 Apr; 18(8):1415-23. PubMed ID: 19174478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
    Bapat S; Galande S
    Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively.
    Palmer A; Qayumi J; Ronnett G
    Mol Cell Neurosci; 2008 Apr; 37(4):794-807. PubMed ID: 18295506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.